This study aims to compare the long-term outcomes of patients with multiple sclerosis (MS) with and without rebound activity after fingolimod discontinuation.
No takes yet. Share an insight, caveat, or question.
Güleç et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: